Malignant hepatoma--controlled therapeutic trials. South African primary liver cancer research group. Initial report.
D000328:Adult; D000477:Alkylating Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000453:epidemiology / Q000401:mortality / Q000532:radiotherapy*; D002986:Clinical Trials as Topic; D006046:Gold; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D008113:Liver Neoplasms; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008906:Mining; D009362:Neoplasm Metastasis; D013019:South Africa
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D006834:Hydrazines; D006046:Gold